(MENAFN- IMARC Group)
IMARC Group has recently released a new research study titled“ Viral Inactivation Market: Global industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 ”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios.
How big is the viral inactivation market?
The global
viral inactivation market
size reached US$ 577.3 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,028.4 Million by 2028, exhibiting a growth rate (CAGR) of 9.4% during 2023-2028.
Industry Overview:
Viral inactivation plays a crucial role in enhancing the safety of biotherapeutic products by preventing viral contamination. During the production process, biotherapeutic products can be infected with viruses that have the potential to invade cells and cause diseases. To counter this, viral inactivation methods are widely utilized to disrupt the coat proteins and degrade the nucleic acid within the viruses. These methods are available in various forms, which are tailored to the specific properties of the virus and the type of biotherapeutic product, leading to the increasing adoption of virus inactivation techniques across the globe.
Request to Get the Sample Report:
https://www.imarcgroup.com/viral-inactivation-market/requestsample
Viral Inactivation Market Trends and Growth Drivers:
The growing concerns among individuals towards the transmission of blood-borne viruses through plasma-derived solutions are primarily driving the viral inactivation market. Besides this, the escalating demand for these technologies and derivatives in the food and beverage (F&B) industry to control the transmission of enteric viruses and ensure meal safety is further augmenting the market growth. Moreover, the launch of several favorable policies by government bodies across countries that necessitate the use of viral inactivation methods to ensure the safety, quality, and efficacy of plasma-derived protein solutions and reduce the risk of cross-contamination is also catalyzing the global market.
Apart from this, continuous technological advancements to expand a wide array of applications for this process are acting as significant growth-inducing factors. Furthermore, the development of new physical methods, such as supercritical fluids, gas plasma, and pulsed electric fields, that provide reliability and convenience is anticipated to propel the viral inactivation market over the forecasted period.
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Charles River Laboratories (NYSE: CRL) Merck KGaA Parker Hannifin Corp Rad Source Technologies Sartorius AG SGS SA Terumo Corporation Texcell Vironova AB WuXi AppTec
Key Market Segmentation:
The report has segmented the global viral inactivation market on the basis of product, application, end use and region.
Breakup by Product:
Reagents and Kits Systems Services
Breakup by Application:
Vaccines and Therapeutics Stem Cell Products Blood and Blood Products Tissue and Tissue Products Cellular and Gene Therapy
Breakup by End Use:
Pharmaceutical and Biotechnology Companies CROs Academic and Research Institutes Others
Regional Analysis:
North America Asia Pacific Europe Latin America Middle East and Africa
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email:
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
MENAFN27022024004122016232ID1107905072
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.